Stocks · Health care · Biological Products, (No Diagnostic Substances)

NEUROCRINE BIOSCIENCES INC

NBIX Clue Score82
United States Fiscal year ends December CIK 0000914475 Results filed 2 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
George J Morrow
3 Nov 2026
Director
Sold after exercise
1,300
$168.53
$219.09K
George J Morrow
3 Nov 2026
Director
Sold after exercise
1,500
$167.72
$251.59K
George J Morrow
3 Nov 2026
Director
Sold after exercise
1,466
$166.77
$244.49K
George J Morrow
3 Nov 2026
Director
Sold after exercise
908
$165.71
$150.46K
George J Morrow
3 Nov 2026
Director
Sold after exercise
1,226
$164.74
$201.97K
George J Morrow
3 Nov 2026
Director
Sold after exercise
600
$163.71
$98.22K
George J Morrow
3 Nov 2026
Director
Sold after exercise
100
$162.05
$16.21K
George J Morrow
3 Nov 2026
Director
Sold after exercise
100
$158.18
$15.82K
George J Morrow
2 Nov 2026
Director
Sold after exercise
1,300
$146.76
$190.78K
George J Morrow
2 Nov 2026
Director
Sold after exercise
4,300
$145.86
$627.19K
George J Morrow
2 Nov 2026
Director
Sold after exercise
1,900
$144.98
$275.45K
George J Morrow
30 Oct 2026
Director
Sold after exercise
300
$149.00
$44.70K
Matt Abernethy
14 Sep 2026
Chief Financial Officer
Sold on a plan
2,311
$157.20
$363.28K
David W. Boyer
14 Sep 2026
Chief Corp. Affairs Officer
Sold on a plan
826
$157.45
$130.05K
Eric Benevich
9 Sep 2026
Chief Commercial Officer
Sold after exercise
2,154
$154.61
$333.03K
Leslie Norwalk V
29 Jul 2026
Director
Exercised, kept
842
$139.43
$117.40K
Leslie Norwalk V
28 Jul 2026
Director
Sold on a plan
1,250
$182.01
$227.51K
Ingrid Delaet
10 Jul 2026
Chief Regulatory Officer
Sold after exercise
4,367
$181.02
$790.51K
Ingrid Delaet
9 Jul 2026
Chief Regulatory Officer
Sold after exercise
8,433
$178.72
$1.51M
Darin Lippoldt
9 Jul 2026
Chief Legal Officer
Sold after exercise
10,000
$179.60
$1.80M
Ingrid Delaet
8 Jul 2026
Chief Regulatory Officer
Sold after exercise
2,737
$178.54
$488.67K
Ingrid Delaet
7 Jul 2026
Chief Regulatory Officer
Sold after exercise
3,401
$178.57
$607.31K
Darin Lippoldt
29 Jun 2026
Chief Legal Officer
Sold after exercise
1,690
$170.81
$288.68K
Darin Lippoldt
29 Jun 2026
Chief Legal Officer
Sold after exercise
8,110
$170.03
$1.38M
Darin Lippoldt
26 Jun 2026
Chief Legal Officer
Sold after exercise
200
$169.57
$33.91K
Stephen A Sherwin
5 Jun 2026
Director
Sold after exercise
1,843
$167.31
$308.36K
Stephen A Sherwin
5 Jun 2026
Director
Sold after exercise
5,829
$166.56
$970.86K
Stephen A Sherwin
5 Jun 2026
Director
Sold after exercise
6,896
$165.79
$1.14M
Stephen A Sherwin
5 Jun 2026
Director
Sold after exercise
2,549
$164.44
$419.16K
Stephen A Sherwin
5 Jun 2026
Director
Sold after exercise
7,883
$163.81
$1.29M
Leslie Norwalk V
4 Jun 2026
Director
Sold on a plan
1,250
$168.06
$210.07K
Julie Cooke
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
3,520
$158.59
$558.24K
Julie Cooke
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
9,521
$157.62
$1.50M
Julie Cooke
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
4,216
$156.77
$660.93K
Julie Cooke
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
5,466
$155.46
$849.73K
Julie Cooke
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
14,214
$154.83
$2.20M
Jude Onyia
1 Jun 2026
Chief Scientific Officer
Sold after exercise
11,000
$160.25
$1.76M
Ingrid Delaet
29 May 2026
Chief Regulatory Officer
Sold after exercise
2,261
$156.71
$354.32K
Jude Onyia
27 May 2026
Chief Scientific Officer
Sold after exercise
11,000
$155.53
$1.71M
David W. Boyer
26 May 2026
Chief Corp. Affairs Officer
Sold on a plan
3,888
$156.64
$609.02K
Kevin Charles Gorman
19 May 2026
Director
Sold after exercise
245,088
$154.33
$37.82M
Richard F Pops
15 May 2026
Director
Sold after exercise
15,000
$157.65
$2.36M
Leslie Norwalk V
12 May 2026
Director
Sold on a plan
3,810
$155.01
$590.60K
Kyle Gano
16 Jan 2026
Chief Executive Officer
Sold after exercise
1,812
$132.71
$240.48K
Kyle Gano
16 Jan 2026
Chief Executive Officer
Sold after exercise
34,588
$132.70
$4.59M
Darin Lippoldt
8 Jan 2026
Chief Legal Officer
Exercised, kept
3,349
$35.99
$120.53K
Leslie Norwalk V
16 Dec 2025
Director
Sold on a plan
1,190
$155.09
$184.56K
Leslie Norwalk V
15 Dec 2025
Director
Sold after exercise
5,000
$152.23
$761.14K
Darin Lippoldt
8 Dec 2025
Chief Legal Officer
Sold after exercise
4,376
$159.65
$698.62K
Gary A Lyons
3 Dec 2025
Director
Sold after exercise
15,000
$152.61
$2.29M
Eric Benevich
28 Nov 2025
Chief Commercial Officer
Sold after exercise
5,970
$151.74
$905.88K
George J Morrow
25 Nov 2025
Director
Sold after exercise
15,000
$143.37
$2.15M

What was left out

Form 4 filings counted 81
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 43
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 967,157
History held since 16 Jan 2007